SerpinB3 as a Pro-Inflammatory Mediator in the Progression of Experimental Non-Alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease (NAFLD) is becoming the most common chronic liver disease worldwide. In 20-30% of patients, NAFLD can progress into non-alcoholic steatohepatitis (NASH), eventually leading to fibrosis, cirrhosis and hepatocellular carcinoma development. SerpinB3 (SB3), a hypoxia-in...

Descripción completa

Detalles Bibliográficos
Autores principales: Novo, Erica, Cappon, Andrea, Villano, Gianmarco, Quarta, Santina, Cannito, Stefania, Bocca, Claudia, Turato, Cristian, Guido, Maria, Maggiora, Marina, Protopapa, Francesca, Sutti, Salvatore, Provera, Alessia, Ruvoletto, Mariagrazia, Biasiolo, Alessandra, Foglia, Beatrice, Albano, Emanuele, Pontisso, Patrizia, Parola, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304805/
https://www.ncbi.nlm.nih.gov/pubmed/35874657
http://dx.doi.org/10.3389/fimmu.2022.910526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304805/
https://www.ncbi.nlm.nih.gov/pubmed/35874657
http://dx.doi.org/10.3389/fimmu.2022.910526

Ejemplares similares